• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性ST2预处理可减轻肝脏热缺血/再灌注损伤。

Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury.

作者信息

Yin Hui, Huang Bao-Jun, Yang Heng, Huang Ya-Fei, Xiong Ping, Zheng Fang, Chen Xiao-Ping, Chen Yi-Fa, Gong Fei-Li

机构信息

Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People' Republic of China.

出版信息

Biochem Biophys Res Commun. 2006 Dec 29;351(4):940-6. doi: 10.1016/j.bbrc.2006.10.166. Epub 2006 Nov 7.

DOI:10.1016/j.bbrc.2006.10.166
PMID:17097607
Abstract

The interleukin-1 receptor-like protein ST2 exists in both membrane-bound (ST2L) and soluble form (sST2). ST2L has been found to play an important regulatory role in Th2-type immune response, but the function of soluble form of ST2 remains to be elucidated. In this study, we report the protective effect of soluble ST2 on warm hepatic ischemia/reperfusion injury. We constructed a eukaryotic expression plasmid, psST2-Fc, which expresses functional murine soluble ST2-human IgG1 Fc (sST2-Fc) fusion protein. The liver damage after ischemia/reperfusion was significantly attenuated by the expression of this plasmid in vivo. sST2-Fc remarkably inhibited the activation of Kupffer cells and the production of proinflammatory mediators TNF-alpha and IL-6. Furthermore, the levels of TLR4 mRNA and the nuclear translocation of NF-kappaB were also suppressed by pretreatment with sST2-Fc. These results thus identified soluble ST2 as a negative regulator in hepatic I/R injury, possibly via ST2-TLR4 pathway.

摘要

白细胞介素-1受体样蛋白ST2以膜结合形式(ST2L)和可溶性形式(sST2)存在。已发现ST2L在Th2型免疫反应中起重要调节作用,但ST2可溶性形式的功能仍有待阐明。在本研究中,我们报道了可溶性ST2对肝脏热缺血/再灌注损伤的保护作用。我们构建了一个真核表达质粒psST2-Fc,其表达功能性小鼠可溶性ST2-人IgG1 Fc(sST2-Fc)融合蛋白。该质粒在体内的表达显著减轻了缺血/再灌注后的肝损伤。sST2-Fc显著抑制了库普弗细胞的激活以及促炎介质TNF-α和IL-6的产生。此外,sST2-Fc预处理还抑制了TLR4 mRNA水平和NF-κB的核转位。因此,这些结果确定可溶性ST2可能通过ST2-TLR4途径在肝脏缺血/再灌注损伤中作为负调节因子。

相似文献

1
Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury.可溶性ST2预处理可减轻肝脏热缺血/再灌注损伤。
Biochem Biophys Res Commun. 2006 Dec 29;351(4):940-6. doi: 10.1016/j.bbrc.2006.10.166. Epub 2006 Nov 7.
2
ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion.ST2是白细胞介素-1受体(IL-1R)家族成员之一,可减轻肠道缺血再灌注后的炎症反应和致死率。
J Leukoc Biol. 2007 Feb;81(2):492-9. doi: 10.1189/jlb.0606422. Epub 2006 Nov 10.
3
Plasma membrane-bound G protein-coupled bile acid receptor attenuates liver ischemia/reperfusion injury via the inhibition of toll-like receptor 4 signaling in mice.质膜结合型G蛋白偶联胆汁酸受体通过抑制小鼠Toll样受体4信号传导减轻肝脏缺血/再灌注损伤。
Liver Transpl. 2017 Jan;23(1):63-74. doi: 10.1002/lt.24628.
4
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.一种通过ST2/T1抑制Toll样受体4表达来调节脂多糖诱导休克的新途径。
J Immunol. 2001 Jun 1;166(11):6633-9. doi: 10.4049/jimmunol.166.11.6633.
5
Hydrodynamics-based transfection of plasmid encoding receptor activator for nuclear factor kappa B-Fc protects against hepatic ischemia/reperfusion injury in mice.基于流体力学的核因子 κB 受体激活物 Fc 质粒转染可保护小鼠肝缺血/再灌注损伤。
Liver Transpl. 2010 May;16(5):611-20. doi: 10.1002/lt.22030.
6
Adenovirus-mediated overexpression of soluble ST2 provides a protective effect on lipopolysaccharide-induced acute lung injury in mice.腺病毒介导的可溶性 ST2 过表达对脂多糖诱导的小鼠急性肺损伤具有保护作用。
Clin Exp Immunol. 2011 May;164(2):248-55. doi: 10.1111/j.1365-2249.2011.04326.x. Epub 2011 Feb 24.
7
Inhibiting the toll-like receptor 4 Toll/interleukin-1 receptor domain protects against hepatic warm ischemia and reperfusion injury in mice.抑制 Toll 样受体 4 Toll/白细胞介素-1 受体结构域可预防小鼠肝脏热缺血再灌注损伤。
Crit Care Med. 2014 Feb;42(2):e123-31. doi: 10.1097/CCM.0b013e3182a647c1.
8
A novel therapy of murine collagen-induced arthritis with soluble T1/ST2.一种用可溶性T1/ST2治疗小鼠胶原诱导性关节炎的新疗法。
J Immunol. 2004 Jul 1;173(1):145-50. doi: 10.4049/jimmunol.173.1.145.
9
Recombinant ST2 boosts hepatic Th2 response in vivo.重组ST2在体内增强肝脏Th2反应。
J Leukoc Biol. 2007 Jul;82(1):124-32. doi: 10.1189/jlb.1006625. Epub 2007 Apr 5.
10
Pretreatment with interleukin-33 reduces warm hepatic ischemia/reperfusion injury in mice.白细胞介素-33 预处理可减轻小鼠热缺血/再灌注损伤。
Chin Med J (Engl). 2013;126(10):1855-9.

引用本文的文献

1
NLRP3 Inflammasome Activation in Liver Disorders: From Molecular Pathways to Therapeutic Strategies.肝脏疾病中的NLRP3炎性小体激活:从分子途径到治疗策略
J Inflamm Res. 2025 Jun 24;18:8277-8294. doi: 10.2147/JIR.S532908. eCollection 2025.
2
Soluble suppression of tumourigenicity 2 as a predictor of postoperative hepatic failure.可溶性肿瘤抑制因子 2 作为预测术后肝衰竭的指标。
BJS Open. 2024 May 8;8(3). doi: 10.1093/bjsopen/zrae043.
3
Role of Interleukin-33 in -Induced Septicemia.白细胞介素-33 在诱导性败血症中的作用。
Front Immunol. 2020 Oct 15;11:534099. doi: 10.3389/fimmu.2020.534099. eCollection 2020.
4
NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation.NLRP3 炎性小体和 IL-33:非感染性肝炎症的新角色。
Int J Mol Sci. 2018 Sep 12;19(9):2732. doi: 10.3390/ijms19092732.
5
IL-33 exacerbates liver sterile inflammation by amplifying neutrophil extracellular trap formation.白细胞介素-33通过增强中性粒细胞胞外诱捕网的形成来加剧肝脏无菌性炎症。
J Hepatol. 2017 Sep 21. doi: 10.1016/j.jhep.2017.09.010.
6
Soluble IL-33 receptor sST2 inhibits colorectal cancer malignant growth by modifying the tumour microenvironment.可溶性白细胞介素-33 受体 sST2 通过改变肿瘤微环境抑制结直肠癌恶性生长。
Nat Commun. 2016 Nov 24;7:13589. doi: 10.1038/ncomms13589.
7
Can Serum ST2 Levels Be Used as a Marker of Fibrosis in Chronic Hepatitis B Infection?血清ST2水平能否用作慢性乙型肝炎感染中纤维化的标志物?
Medicine (Baltimore). 2015 Nov;94(47):e1889. doi: 10.1097/MD.0000000000001889.
8
Inflammasome activation and function in liver disease.炎症小体的激活及其在肝脏疾病中的作用。
Nat Rev Gastroenterol Hepatol. 2015 Jul;12(7):387-400. doi: 10.1038/nrgastro.2015.94. Epub 2015 Jun 9.
9
Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Behcet's disease.血清白介素-33 和可溶性 ST2 水平及其与白塞病患者疾病活动度的关系。
J Korean Med Sci. 2013 Aug;28(8):1145-53. doi: 10.3346/jkms.2013.28.8.1145. Epub 2013 Jul 31.
10
A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.一种新型白细胞介素 33/ST2 信号通路调节人角膜上皮的炎症反应。
PLoS One. 2013 Apr 9;8(4):e60963. doi: 10.1371/journal.pone.0060963. Print 2013.